RecruitingAortic Stenosis

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Eligible age

18–105 yrs

Accepts

All genders

Locations

31 states

Healthy volunteers

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).

Sponsor: Medtronic Cardiovascular

You may qualify if…

✓ BVF of a TAV (either Medtronic or Edwards) requiring redo TAVR

You may not qualify if…

✕ BVF due solely to paravalvular regurgitation
✕ Active endocarditis
✕ Untreated acute valve thrombosis
✕ Life-expectancy less than 1-year
✕ Subject is less than legal age of consent, legally incompetent, or otherwise vulnerable
✕ Participating in another study that may influence the outcome of this study